1. Home
  2. PSTL vs YDES Comparison

PSTL vs YDES Comparison

Compare PSTL & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Postal Realty Trust Inc.

PSTL

Postal Realty Trust Inc.

HOLD

Current Price

$24.00

Market Cap

625.7M

Sector

Real Estate

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.24

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSTL
YDES
Founded
N/A
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
625.7M
543.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
PSTL
YDES
Price
$24.00
$2.24
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$20.19
N/A
AVG Volume (30 Days)
316.0K
312.1K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
4.62%
N/A
EPS Growth
123.81
N/A
EPS
0.11
N/A
Revenue
$95,823,000.00
N/A
Revenue This Year
$18.01
N/A
Revenue Next Year
$11.38
N/A
P/E Ratio
$216.09
N/A
Revenue Growth
25.47
N/A
52 Week Low
$13.59
$1.70
52 Week High
$25.22
$25.00

Technical Indicators

Market Signals
Indicator
PSTL
YDES
Relative Strength Index (RSI) 48.71 44.84
Support Level $23.71 $2.14
Resistance Level $24.28 $3.05
Average True Range (ATR) 0.53 0.32
MACD -0.10 0.07
Stochastic Oscillator 16.78 59.36

Price Performance

Historical Comparison
PSTL
YDES

About PSTL Postal Realty Trust Inc.

Postal Realty Trust Inc is an internally managed real estate investment trust. It is engaged in acquiring and managing properties mainly leased to the United States Postal Service, or the USPS, ranging from last-mile post offices to industrial facilities. The Trust's objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of its revenue is generated in the form of rental income.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: